Patient | Pharma Marketer

Adventrx Pharma Sets Out to Improve Current Cancer Drugs

Wednesday, August 11th, 2010

Douglas Cress submits: B y vanderson Chemotherapy drugs are powerful anti-cancer agents, but they can also cause adverse side effects such as rashes, nausea, and allergic reactions. Reformulating a popular drug offers pharmaceutical companies the opportunity to preserve a drug’s known strengths while reducing its weaknesses. Although reformulation can be a way for pharmaceutical companies to get more mileage out of a drug that’s about to go off-patent, it can benefit the patient as well

Posted in: Pharma News | 0 Comments »

Read the full story

Should doctors use social media ?

Wednesday, July 14th, 2010

Should physicians use social media for professional purposes ? That is a huge question that most health care professionals are going to have to answer. The first thing they need to determine is the objective for using social media.

Posted in: DTC | 0 Comments »

Read the full story

Annual cost of non-compliance ? $163 billion

Thursday, June 24th, 2010

Three simple behaviors can achieve savings in healthcare.

Posted in: DTC | 0 Comments »

Read the full story

Think you control your pharma brand ? Think again…

Saturday, June 12th, 2010

If you think you are in control of your brand just take a look at what has happened to Avandia; ▪ An unpublished study, which has not been peer reviewed or objectively scrutinized, states that using Avandia has led to the possibility of over 48,000 deaths by heart attack. ▪ The FDA is still evaluating the “data” for Avandia and has not specifically recommended if the drug is safe for patients. Now if you’re a physician who has prescribed Avandia and a patient comes to you and wants to know if it’s still safe to take what do you do

Posted in: DTC, Social Media | 0 Comments »

Read the full story

Now let’s attack free pharma samples because physicians shouldn’t give them to patients

Friday, June 4th, 2010

According to an article in today’s WSJ; Shahram Ahari, a former Eli Lilly drug-sales representative, said samples helped him gain access and cement relationships with physicians. Mr. Ahari gave out samples of the depression medicine Prozac and schizophrenia treatment Zyprexa; he recalled having perhaps $200,000 worth of free medicines in his car and garage at any one point.

Posted in: DTC | 1 Comment »

Read the full story

AMG 479 shows "promising activity" in pancratic cancer

Friday, June 4th, 2010

Data from a

Posted in: Pharma News | 0 Comments »

Read the full story

Immunocellular Therapeutics’ Brain Cancer Vaccine Extends Survival Rate in Small Trial

Thursday, June 3rd, 2010

Douglas Cress submits: By vanderson A brain cancer vaccine from Immunocellular Therapeutics ( IMUC.OB ) has yielded positive results in a small Phase I clinical trial, reports Fierce Biotech. The study involved only 16 patients with glioblastoma multiforme, the most common form of brain cancer.

Posted in: Pharma News | 0 Comments »

Read the full story

Wyeth Marketing Targeted Blacks Illegally: Lawsuit

Monday, May 24th, 2010

A pair of former hospital sales reps filed a whistleblower suit alleging Wyeth, which is now owned by Pfizer, illegally promoted its Rapamune kidney transplant drug for use with other organs and targeted African-Americans, even though this is a high-risk patient group, according to the product labeling . The suit was filed by Marlene Sandler and Scott Paris in 2005, but was recently unsealed and an amended complaint was filed today ( see the suit )

Posted in: Pharma News | 0 Comments »

Read the full story